Showcasing the Power of Australian Manufacturing and Strengthening China–Australia Trade
On 22 May 2025, at the 10th Anniversary Gala of the China–Australia Free Trade Agreement (ChAFTA) held at NSW Parliament House, Homart Group was honoured with the prestigious “Best Achievement of CIIE” award. This accolade recognises companies that have made outstanding contributions to bilateral trade between China and Australia. It also marks Homart’s 26th international award, reaffirming the company’s global influence and long-term commitment to the health and wellness industry.
As a key player in Australia’s health sector, Homart has participated in the China International Import Expo (CIIE) six times since its inaugural edition in 2018. At the 7th CIIE in 2024, Homart’s booth attracted more than 100,000 visitors, drawing attention from industry leaders, media, and government representatives. The brand was also featured in CCTV’s “Made in Power” program, highlighting its role as a standout example of Australian manufacturing.
Presented during Australian Made Week (19–25 May), the award underscores the important role Australian-made brands play in building global trade partnerships and consumer trust. Today, Homart owns and operates 14 premium Australian brands, including SpringLeaf, Thompson’s, Thursday Plantation, AUTILI, PETMIMA, Toplife, CHERI, and Grandpawpaw — spanning health supplements, skincare, infant nutrition, and pet care.
Since its founding in 1992, Homart has remained committed to its mission: “Made in Australia, Healthy the World.” The Group has achieved consistent year-on-year profitability and reported double growth in both revenue and profit in FY2025. Homart is now actively preparing for its listing on the main board of the Australian Securities Exchange (ASX), entering a new phase of global expansion. In China, the Group operates over 30 flagship stores across major cross-border e-commerce platforms, with products widely available in pharmacy chains, maternity stores, and online channels. Many of its products have received “Blue Hat” certification for large-scale health product importation, as well as certifications for pet supplements.
Earlier that day, during the ChAFTA forum, Homart CEO and Founder Ms. Lynn Yeh delivered a keynote address and joined discussions with business and government leaders — including the CEO of Australian Made and former Australian Trade Ministers — on topics such as brand internationalisation, Australia’s manufacturing advantages, and the future of bilateral cooperation. As a long-standing CIIE exhibitor, Homart was recognised as a crucial bridge between the Australian and Chinese health industries.
Looking Ahead
This recognition is not only a celebration of Homart’s achievements in the Chinese market — it’s also a strong affirmation of the Group’s commitment to innovation, product excellence, and cross-border collaboration.
Moving forward, Homart will continue to drive global growth through innovation, quality, and strategic partnerships — delivering trusted Australian health solutions to the world.
